BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1335085)

  • 1. Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
    Sørensen BS; Sinding J; Andersen AH; Alsner J; Jensen PB; Westergaard O
    J Mol Biol; 1992 Dec; 228(3):778-86. PubMed ID: 1335085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216.
    Sørensen BS; Jensen PS; Andersen AH; Christiansen K; Alsner J; Thomsen B; Westergaard O
    Biochemistry; 1990 Oct; 29(41):9507-15. PubMed ID: 2176847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate.
    Anderson AH; Sørensen BS; Christiansen K; Svejstrup JQ; Lund K; Westergaard O
    J Biol Chem; 1991 May; 266(14):9203-10. PubMed ID: 1851170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.
    Robinson MJ; Osheroff N
    Biochemistry; 1991 Feb; 30(7):1807-13. PubMed ID: 1847075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Robinson MJ; Osheroff N
    Biochemistry; 1990 Mar; 29(10):2511-5. PubMed ID: 2159323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediate.
    Gale KC; Osheroff N
    Biochemistry; 1990 Oct; 29(41):9538-45. PubMed ID: 2176849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.
    Osheroff N
    Biochemistry; 1989 Jul; 28(15):6157-60. PubMed ID: 2551366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.
    Zechiedrich EL; Christiansen K; Andersen AH; Westergaard O; Osheroff N
    Biochemistry; 1989 Jul; 28(15):6229-36. PubMed ID: 2551367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.
    Svejstrup JQ; Christiansen K; Gromova II; Andersen AH; Westergaard O
    J Mol Biol; 1991 Dec; 222(3):669-78. PubMed ID: 1660929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction.
    Andersen AH; Christiansen K; Zechiedrich EL; Jensen PS; Osheroff N; Westergaard O
    Biochemistry; 1989 Jul; 28(15):6237-44. PubMed ID: 2551368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CPT on the DNA cleavage/religation reaction mediated by calf thymus Topoisomerase I: evidence of an inhibition of DNA religation. Inhibition of Topoisomerase I-mediated DNA religation by CPT.
    Carboni MC; Coderoni S
    Mol Biol Rep; 1994-1995; 20(3):129-33. PubMed ID: 7565652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF; Corbett AH; Osheroff N
    Cancer Res; 1992 Apr; 52(8):2156-61. PubMed ID: 1313738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
    Bigioni M; Zunino F; Tinelli S; Austin CA; Willmore E; Capranico G
    Biochemistry; 1996 Jan; 35(1):153-9. PubMed ID: 8555169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic activities of DNA topoisomerase II are most closely associated with the DNA cleavage/religation steps.
    Scala D; Escargueil AE; Couprie J; Larsen AK
    Biochimie; 1999 Jul; 81(7):771-9. PubMed ID: 10492025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA cleavage.
    Arimondo P; Bailly C; Boutorine A; Asseline U; Sun JS; Garestier T; Hélène C
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1205-18. PubMed ID: 11097051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle.
    Sehested M; Jensen PB
    Biochem Pharmacol; 1996 Apr; 51(7):879-86. PubMed ID: 8651936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.